In vitro evaluation of a novel 2,6,9-trisubstituted purine acting as a cyclin-dependent kinase inhibitor.
Giocanti
N
N
U 350 INSERM, Orsay, France.
Sadri
R
R
Legraverend
M
M
Ludwig
O
O
Bisagni
E
E
Leclerc
S
S
Meijer
L
L
Favaudon
V
V
D000970:Antineoplastic Agents / Q000494:pharmacology*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D011687:Purines / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D011687:Purines; D018844:Cyclin-Dependent Kinases